Golden Seeds Cognition Therapeutics LLC is > 10% Shareholder of COGNITION THERAPEUTICS INC. Currently has a direct ownership of 0 shares of CGTX, which is worth approximately $0. The most recent transaction as insider was on Sep 27, 2022, when has been sold 2,489,682 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Golden Seeds Cognition Therapeutics LLC Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 27 2022
SELL
Other acquisition or disposition
-
2,489,682 Reduced 100.0%
0 Common Stock
Oct 13 2021
SELL
Open market or private sale
$396 $12.0 p/Share
33 Reduced 0.0%
2,177,985 Common Stock
Oct 13 2021
BUY
Exercise of in-the-money or at-the-money derivatives securities
$368 $0.03 p/Share
12,276 Added 0.56%
2,178,019 Common Stock
Oct 13 2021
BUY
Conversion of derivative security
-
2,477,449 Added 49.88%
2,489,691 Common Stock
GSC

Golden Seeds Cognition Therapeutics LLC

> 10% Shareholder
Purchase, NY

Track Institutional and Insider Activities on CGTX

Follow COGNITION THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells CGTX shares.

Notify only if

Insider Trading

Get notified when an Cognition Therapeutics Inc insider buys or sells CGTX shares.

Notify only if

News

Receive news related to COGNITION THERAPEUTICS INC

Track Activities on CGTX